Harvard Bioscience Inc
NASDAQ:HBIO

Watchlist Manager
Harvard Bioscience Inc Logo
Harvard Bioscience Inc
NASDAQ:HBIO
Watchlist
Price: 0.6704 USD -2.91% Market Closed
Market Cap: 29.9m USD

During the last 3 months Harvard Bioscience Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 51% over this period (open performance analysis).

The last transaction was made on Jun 13, 2024 by Green James W , who bought 29.1k USD worth of HBIO shares.

Last Transactions:
Green James W
$+29.1k
Green James W
$+61.4k
Green James W
$+109.5k
Green James W
$+52k
Edrick Alan I
$+42.4k
Green James W
$+53.4k
Edrick Alan I
$+36.9k
Green James W
$+39.2k
Green James W
$+36.2k
Loy Bertrand
$+31.7k
Loy Bertrand
$+27.5k
Loy Bertrand
$+55.8k
Loy Bertrand
$+28.9k
Loy Bertrand
$+15.5k
Loy Bertrand
$+31.5k
Loy Bertrand
$+3.7k
Green James W
$+127.6k
Green James W
$+111.3k
Green James W
$+34k
Green James W
$+113.4k
Green James W
$-386.4k
Green James W
$-173.6k
Green James W
$-104.6k
Green James W
$-281k
Green James W
$-290.4k
Green James W
$-209.3k
Edrick Alan I
$+52.5k
Green James W
$+25.3k
Loy Bertrand
$+15.4k
Loy Bertrand
$+26.6k
Loy Bertrand
$+33.3k
Green James W
$+26.1k
View All Transactions

During the last 3 months Harvard Bioscience Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 51% over this period (open performance analysis).

The last transaction was made on Jun 13, 2024 by Green James W , who bought 29.1k USD worth of HBIO shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

Harvard Bioscience Inc
Insider Trading Chart

Harvard Bioscience Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Harvard Bioscience Inc
Last Insider Transactions

Global
Insiders Monitor

Harvard Bioscience Inc
Glance View

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. The company is headquartered in Holliston, Massachusetts and currently employs 475 full-time employees. The company went IPO on 2013-10-21. The firm provides products that support research in six different classes of laboratory use, including molecular, cellular, tissue, organ, organisms or preclinical, and clinical. The firm organizes its product line activities into two product families, Cellular and Molecular Technologies (CMT) and Preclinical. The company primarily sells its products under several brand names, including Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS. The firm's customers include pharmaceutical and biotechnology companies, as well as contract research organizations, academic labs, and government researchers.

HBIO Intrinsic Value
2.5443 USD
Undervaluation 74%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top